Financials

News Ideas Technicals

086060 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to GENEBIOTECH operating, investing, and financing activities

086060 free cash flow for Q4 23 is 2.86 B KRW. For 2023, 086060 free cash flow was 6.84 B KRW and operating cash flow was 7.37 B KRW.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: KRW

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—